PMID: 19148507Jan 17, 2009Paper

Clinical significance of Smac/DIABLO expression in colorectal cancer

Oncology Reports
Kazuya EndoYoshihiko Maehara

Abstract

Second mitochondria-derived activator of caspases/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) is released by mitochondria in response to apoptotic stimuli and is thought to regulate apoptosis by antagonizing inhibitors of apoptosis proteins, which play an important role in sensitization of cancer cells to various therapeutic regimens. The expression of Smac/DIABLO has been demonstrated in various cancer cells, though little is known about its clinical significance with respect to colorectal cancer. The current study was designed to evaluate the relationship between prognosis and Smac/DIABLO expression by clinicopathological analysis of patients with colorectal cancer. Smac/DIABLO expression was evaluated using immunohistochemical staining in 121 consecutive patients with colorectal cancer and the relationship between Smac/DIABLO expression and clinicopathological factors was analyzed. Smac/DIABLO-positive expression was detected in 80 of the 121 patients (66%). The incidence of lymph node and distant metastasis in Smac/DIABLO-negative cancer was significantly higher than that in Smac/DIABLO-positive cancer (P=0.0004 and P=0.003, respectively). While univariate analysis showed that survival in patient...Continue Reading

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Hepatobiliary & Pancreatic Diseases International : HBPD INT
Shi-Ting BaoMu-Sheng Lin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Yoichi MizutaniTsuneharu Miki
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Zhenqian WuYu Wang
Journal of Experimental & Clinical Cancer Research : CR
Gustavo Martinez-RuizJorge Melendez-Zajgla
© 2021 Meta ULC. All rights reserved